Luts & Greenleigh Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-771
Closed -$255K 94
2025
Q4
$255K Sell
771
-1
-0.1% -$339 0.22% 75
2025
Q3
$267K Buy
772
+25
+3% +$7.56K 0.24% 69
2025
Q2
$233K Sell
747
-96
-11% -$36.7K 0.22% 74
2025
Q1
$442K Sell
843
-6
-0.7% -$3.07K 0.44% 46
2024
Q4
$430K Sell
849
-51
-6% -$29K 0.42% 46
2024
Q3
$526K Buy
900
+98
+12% +$55.4K 0.51% 42
2024
Q2
$408K Buy
+802
New +$393K 0.42% 45
2023
Q4
$395K Sell
750
-40
-5% -$21.3K 0.5% 41
2023
Q3
$399K Sell
790
-213
-21% -$105K 0.49% 38
2023
Q2
$482K Sell
1,003
-172
-15% -$84.1K 0.59% 36
2023
Q1
$555K Buy
1,175
+72
+7% +$34.7K 0.7% 30
2022
Q4
$585K Buy
+1,103
New +$584K 0.74% 26

Other funds holding UNH

Luts & Greenleigh Group's UNH Position: Q1 2026 in Review

Luts & Greenleigh Group sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 771 shares — an estimated $255K sold.

Luts & Greenleigh Group first reported a position in UNH in Q4 2022 and held it in 12 quarters. The position peaked at $585K in Q4 2022. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Luts & Greenleigh Group reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
  • Luts & Greenleigh Group sold 771 UnitedHealth shares in Q1 2026, an estimated $255K.
  • Luts & Greenleigh Group first reported a position in UnitedHealth in Q4 2022 and held it in 12 quarters.
  • Luts & Greenleigh Group's UnitedHealth position peaked at $585K in Q4 2022.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Luts & Greenleigh Group's 13F filing for Q1 2026, filed 5 May 2026.